AMICUS THERAPEUTICS, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Amicus Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2012 to Q2 2024.
  • Amicus Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $16.2M, a 2.29% decline year-over-year.
  • Amicus Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $81.6M, a 3.85% decline year-over-year.
  • Amicus Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $86.1M, a 12.5% increase from 2022.
  • Amicus Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $76.5M, a 32.3% increase from 2021.
  • Amicus Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $57.8M, a 17.7% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $81.6M $16.2M -$380K -2.29% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $82M $30.8M -$4.09M -11.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $86.1M $18.1M -$531K -2.85% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $86.6M $16.5M +$1.74M +11.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $84.9M $16.6M +$4.11M +33% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $80.8M $34.9M +$4.24M +13.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $76.5M $18.6M +$4.72M +33.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $71.8M $14.8M +$2.93M +24.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $68.9M $12.5M +$727K +6.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $68.1M $30.7M +$10.3M +50.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $57.8M $13.9M +$1.67M +13.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $56.2M $11.8M -$4.07M -25.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $60.2M $11.7M +$3.33M +39.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $56.9M $20.4M +$7.76M +61.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $49.2M $12.2M -$669K -5.18% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $49.8M $15.9M +$7.07M +79.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $42.8M $8.41M -$1.53M -15.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $44.3M $12.6M -$148K -1.16% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $44.4M $12.9M +$4.52M +53.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $39.9M $8.84M +$1.79M +25.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $38.1M $9.94M +$3.59M +56.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $34.5M $12.7M +$5.27M +70.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $29.3M $8.39M +$2.35M +39% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $26.9M $7.05M +$1.55M +28.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $25.4M $6.34M +$804K +14.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $24.5M $7.48M +$1.45M +24% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $23.1M $6.03M +$1.62M +36.6% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $21.5M $5.5M +$1.16M +26.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 $20.3M $5.54M +$1.07M +24% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $19.3M $6.03M +$1.75M +40.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $17.5M $4.42M +$1.37M +45.1% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $16.1M $4.34M +$1.6M +58.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $14.5M $4.47M +$2.24M +100% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $12.3M $4.28M +$2.32M +119% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $9.97M $3.04M +$1.44M +89.4% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 $8.54M $2.74M +$1.09M +65.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $7.45M $2.23M +$741K +49.7% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $6.71M $1.96M +$700K +55.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-03
Q4 2014 $6.01M $1.61M +$104K +6.92% Oct 1, 2014 Dec 31, 2014 10-K/A 2017-03-03
Q3 2014 $5.9M $1.65M +$134K +8.83% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 $5.77M $1.49M -$93K -5.88% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $5.86M $1.26M -$314K -19.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 $6.18M $1.5M +$55K +3.8% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $6.12M $1.52M -$81K -5.07% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $6.2M $1.58M -$174K -9.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $6.38M $1.57M +$186K +13.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-05
Q4 2012 $6.19M $1.45M Oct 1, 2012 Dec 31, 2012 10-K 2015-03-03
Q3 2012 $1.6M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $1.76M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 $1.39M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.